Hemolytic anemia laboratory findings: Difference between revisions

Jump to navigation Jump to search
Line 15: Line 15:
* Absolute reticulocyte count - 25,000 to 75,000/microLitre  
* Absolute reticulocyte count - 25,000 to 75,000/microLitre  
===Peripheral blood smear===
===Peripheral blood smear===
**Fragments of the red blood cells ("[[schistocyte]]s") can be present.
* Fragments of the red blood cells ("[[schistocyte]]s") can be present.
**Some red blood cells may appear smaller and rounder than usual ([[spherocyte]]s).
* Some red blood cells may appear smaller and rounder than usual ([[spherocyte]]s).
**[[Reticulocytosis|Reticulocytes]] are present in elevated numbers. This may be overlooked if a special [[staining (biology)|stain]] is not used.
* [[Reticulocytosis|Reticulocytes]] are present in elevated numbers. This may be overlooked if a special [[staining (biology)|stain]] is not used.
*The level of unconjugated [[bilirubin]] in the blood is elevated.  This may lead to [[jaundice]].
===Liver function test===
* The level of unconjugated [[bilirubin]] in the blood is elevated.  This may lead to [[jaundice]].
*The level of [[lactate dehydrogenase]] (LDH) in the blood is elevated.
*The level of [[lactate dehydrogenase]] (LDH) in the blood is elevated.
*[[Haptoglobin]] levels are decreased.
*[[Haptoglobin]] levels are decreased.

Revision as of 14:10, 25 September 2012


Hemolytic anemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemolytic anemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT Scan

MRI Scan

Echocardiography or Ultrasound

Imaging Findings

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemolytic anemia laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemolytic anemia laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemolytic anemia laboratory findings

CDC on Hemolytic anemia laboratory findings

Hemolytic anemia laboratory findings in the news

Blogs on Hemolytic anemia laboratory findings

Directions to Hospitals Treating Hemolytic anemia

Risk calculators and risk factors for Hemolytic anemia laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Hemolytic anemia is anemia caused secondary to shortened survival of circulating red blood cells. The normal life span of RBCs is 110 to 120 days. RBC destruction before that time is defined as hemolytic anemia. As opposed to the normal senecence of RBC, the random hemolysis (premature RBC death) is increased in hemolytic anemia.

Laboratory Findings

Absolute reticulocyte count

The normal values are:

  • RBC count - 5 million/microLitre
  • Reticulocyte count - 0.5 -1.5 %
  • Absolute reticulocyte count - 25,000 to 75,000/microLitre

Peripheral blood smear

  • Fragments of the red blood cells ("schistocytes") can be present.
  • Some red blood cells may appear smaller and rounder than usual (spherocytes).
  • Reticulocytes are present in elevated numbers. This may be overlooked if a special stain is not used.

Liver function test

  • The level of unconjugated bilirubin in the blood is elevated. This may lead to jaundice.
  • The level of lactate dehydrogenase (LDH) in the blood is elevated.
  • Haptoglobin levels are decreased.
  • The direct Coombs test is positive if hemolysis is caused by an immune process.
  • Hemosiderin in the urine indicates chronic intravascular hemolysis. There is also urobilinogen in the urine.

(Images shown below are courtesy of Melih Aktan MD, Istanbul Medical Faculty - Turkey, and Hospital Universitario La Fe Servicio Hematologia)

References